近三年股票ETF跌幅榜：疫苗ETF富国跌37.96%，国泰疫苗ETF跌37.68%，鹏华酒ETF跌36.54%

Core Insights - The 2025 stock ETF has shown a remarkable performance with a year-to-date increase of 233%, indicating a strong recovery in active equity investments [1][2] - The overall industry scale is approaching a new high of 36 trillion yuan, reflecting significant growth in the investment sector [1][2] Performance Summary - The 2025 stock ETF's performance from 2023 to 2025 has been officially released, highlighting the substantial gains in certain funds [1][2] - Specific ETFs such as the vaccine ETFs have experienced significant declines, with the 富国 vaccine ETF down by 37.96%, the 国泰 vaccine ETF down by 37.68%, and the 鹏华 wine ETF down by 36.54% over the same period [1][2]